CODE OF PRACTICE
Pathology Technology Australia has developed a Code of Practice for Industry. The Code of Practice provides an ethical framework that governs the interactions between in vitro diagnostic members and the individuals or entities that provide healthcare services to patients or that purchase, lease, recommend, use, or prescribe in vitro diagnostics in Australia.
Adoption of this Code is mandatory for Pathology Technology Members, but those in the industry who are not members are also strongly encouraged to adopt it.
What are the benefits of an industry code of practice?
An industry code of practice provides a range of benefits to both industry, healthcare professionals and consumers such as:
Guidance for Implementing the Code
Pathology Technology Australia will from time to time develop explanatory notes to assist and provide guidance to decision-makers to exercise discretion. Unlike the Pathology Technology Industry Code of Practice, these notes do not have the force and effect of the Code, but they should not be inconsistent with the Code. If they are, the Code takes precedence.
These guidance documents have been prepared by the CEO to assist you with understanding and implementing the Code of Practice. Please note: You must not rely on the information on this website as an alternative to legal advice from your solicitor or other professional legal services provider. If you have any specific questions about any legal matter you should consult your solicitor or other professional legal services provider. You should never delay seeking legal advice, disregard legal advice, or commence or discontinue any legal action because of information in this information sheet or on the Pathology Technology Australia website.